Comparison of the cardiopulmonary effects of anesthesia maintained by continuous infusion of romifidine, guaifenesin, and ketamine with anesthesia maintained by inhalation of halothane in horses. 2002

Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

OBJECTIVE To compare cardiopulmonary responses during anesthesia maintained with halothane and responses during anesthesia maintained by use of a total intravenous anesthetic (TIVA) regimen in horses. METHODS 7 healthy adult horses (1 female, 6 geldings). METHODS Each horse was anesthetized twice. Romifidine was administered IV, and anesthesia was induced by IV administration of ketamine. Anesthesia was maintained for 75 minutes by administration of halothane (HA) or IV infusion of romifidine, guaifenesin, and ketamine (TIVA). The order for TIVA or HA was randomized. Cardiopulmonary variables were measured 40, 60, and 75 minutes after the start of HA orTIVA. RESULTS Systolic, diastolic, and mean carotid arterial pressures, velocity time integral, and peak acceleration of aortic blood flow were greater, and systolic, diastolic, and mean pulmonary arterial pressure were lower at all time points for TIVA than for HA. Pre-ejection period was shorter and ejection time was longer for TIVA than for HA. Heart rate was greater for HA at 60 minutes. Minute ventilation and alveolar ventilation were greater and inspiratory time was longer for TIVA than for HA at 75 minutes. The PaCO2 was higher at 60 and 75 minutes for HA than forTIVA. CONCLUSIONS Horses receiving a constant-rate infusion of romifidine, guaifenesin, and ketamine maintained higher arterial blood pressures than when they were administered HA. There was some indication that left ventricular function may be better during TIVA, but influences of preload and afterload on measured variables could account for some of these differences.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007649 Ketamine A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D005260 Female Females
D006140 Guaifenesin An expectorant that also has some muscle relaxing action. It is used in many cough preparations. Guaiacol Glyceryl Ether,Guaiphenesin,Breonesin,Glycerol Guaiacolate,Guaiphenezine,Guiatuss,Humibid,Hytuss,My-301,Scott-Tussin,Ether, Guaiacol Glyceryl,Glyceryl Ether, Guaiacol,Guaiacolate, Glycerol,My 301,My301,Scott Tussin,ScottTussin
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan

Related Publications

Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
November 1986, American journal of veterinary research,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
October 2002, Journal of the American Veterinary Medical Association,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
March 2001, American journal of veterinary research,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
July 1998, Equine veterinary journal,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
June 1993, The Veterinary record,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
March 2000, The Journal of veterinary medical science,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
January 2008, Veterinary anaesthesia and analgesia,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
November 1993, American journal of veterinary research,
Rose M McMurphy, and Lesley E Young, and David J Marlin, and Karen Walsh
January 1991, Laboratory animal science,
Copied contents to your clipboard!